コンテンツへスキップ
Merck

Clinical practice: Acute high-altitude illnesses.

The New England journal of medicine (2013-06-14)
Peter Bärtsch, Erik R Swenson
要旨

A 45-year-old healthy man wishes to climb Mount Kilimanjaro (5895 m) in a 5-day period, starting at 1800 m. The results of a recent exercise stress test were normal; he runs 10 km 4 or 5 times per week and finished a marathon in less than 4 hours last year. He wants to know how he can prevent becoming ill at high altitude and whether training or sleeping under normobaric hypoxic conditions in the weeks before the ascent would be helpful. What would you advise?

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
デキサメタゾン, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Dexamethasone-Water Soluble, suitable for cell culture, BioReagent
Sigma-Aldrich
デキサメタゾン, ≥98% (HPLC), powder
Sigma-Aldrich
デキサメタゾン, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
アセタゾールアミド, ≥99%, powder
Supelco
デキサメタゾン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
デキサメタゾン, meets USP testing specifications
Sigma-Aldrich
デキサメタゾン, tested according to Ph. Eur.
Supelco
デキサメタゾン, VETRANAL®, analytical standard
デキサメタゾン, European Pharmacopoeia (EP) Reference Standard
アセタゾールアミド, European Pharmacopoeia (EP) Reference Standard